Busto Arsizio, Italy

Giacomo Carenzi

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Giacomo Carenzi: Innovator in Pharmaceutical Chemistry

Introduction

Giacomo Carenzi is a notable inventor based in Busto Arsizio, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic agents. With a total of five patents to his name, Carenzi's work focuses on innovative compounds that address critical health issues.

Latest Patents

Carenzi's latest patents include groundbreaking inventions such as spirocyclic derivatives that act as histone deacetylase inhibitors. This invention introduces new histone deacetylase inhibitors characterized by a specific general formula, which includes various structural components and pharmaceutical acceptable salts. Another significant patent involves acrylamido derivatives that serve as inhibitors of the mitochondrial permeability transition. These compounds are particularly useful in preventing and treating diseases associated with mitochondrial dysfunction, such as ischemia/reperfusion injuries and oxidative tissue damage.

Career Highlights

Throughout his career, Giacomo Carenzi has worked with several companies, including Dac S.r.l. and Congenia S.r.l. His expertise in pharmaceutical chemistry has allowed him to develop innovative solutions that have the potential to improve patient outcomes.

Collaborations

Carenzi has collaborated with notable colleagues in his field, including Mario Varasi and Saverio Minucci. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Giacomo Carenzi's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the industry. His work continues to pave the way for new therapeutic options that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…